Patients with type 2 diabetes taking JANUVIA® (sitagliptin), metformin initiated insulin therapy at a slower rate compared to patients taking a sulfonylurea, metformin

A late-breaking observational study has been released that assessed the differences in time to initiation of insulin use and the proportion of the population initiating insulin among patients with type 2 diabetes taking the combination of JANUVIA® (sitagliptin) and metformin, and patients taking the combination of a sulfonylurea and metformin.
Source: ScienceDaily Headlines - Category: Science Source Type: news